Hot News

御藥堂先攻台灣再拓內地 @ 2013-10-12T05: Back Hot News
Keyword:御藥堂
Concept:配售上市 , 御藥堂正籌備
至於另外兩間以配售方式上市的毅高國際(8218)及御藥堂(8185),兩間公司的收市價均高於其配售價。其中御藥堂收市價2.79元,較配售價1.07元高出1.61倍。毅高在首日表現屬3只以配售形式上市的新股中最失色的一只,但是事實上並不失禮,收市報0.96元,較配售價高出60%。御藥堂主席陳恩德指出,公司會先做好台灣市場,及後才會進軍內地市場,又指出台灣市場對公司較熟悉。他又指出縱使未來公司在廣告開支會增加,但是營業額亦有增長,相信日後廣告對收入比率,可維持在15%或更低水平。
提及御藥堂(8185),讓人很快聯想到不久前的同仁堂(600085,股吧)(8138),後者於今年5月7日掛牌,首日即翻番,至今累計升幅已達3.5倍。而且他們不僅名字相似,業務也相似,同仁堂經營中藥,御藥堂主攻中成藥保健品,兩者都在各自領域享有較高品牌影響力,都擁有多項產品專利。隨著內地人均收入增多,人們對保健品的需求更甚藥品,而且集團今年進軍台灣市場,料上市表現不俗。兩者相比較而言,短炒必選港深物業(8181),長線可選御藥堂(8185)。

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.